Last reviewed · How we verify
Sham-transplantation (placebo)
Sham-transplantation (placebo) is a Small molecule drug developed by Assistance Publique - Hôpitaux de Paris. It is currently in Phase 3 development for Treatment of various conditions in a clinical trial setting to compare with actual treatment.
Sham-transplantation, also known as placebo treatment, does not involve any actual therapeutic intervention.
Sham-transplantation, also known as placebo treatment, does not involve any actual therapeutic intervention. Used for Treatment of various conditions in a clinical trial setting to compare with actual treatment.
At a glance
| Generic name | Sham-transplantation (placebo) |
|---|---|
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
It is a control treatment used in clinical trials to compare the efficacy of an actual treatment. Sham-transplantation does not have any known mechanism of action as it is essentially a dummy treatment.
Approved indications
- Treatment of various conditions in a clinical trial setting to compare with actual treatment
Common side effects
Key clinical trials
- Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplantation (PHASE2)
- Microbiota Transfer for Chronic Rhinosinusitis (NA)
- A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant (PHASE2)
- Fecal Microbiota Transplantation in Children With ASD (NA)
- Impact of Fecal Microbiota Transplantation in Ulcerative Colitis (PHASE3)
- Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant (PHASE2)
- Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal (PHASE3)
- Study of Fecal Microbiota Transplantation (FMT) in Severe IBS Patients (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sham-transplantation (placebo) CI brief — competitive landscape report
- Sham-transplantation (placebo) updates RSS · CI watch RSS
- Assistance Publique - Hôpitaux de Paris portfolio CI
Frequently asked questions about Sham-transplantation (placebo)
What is Sham-transplantation (placebo)?
How does Sham-transplantation (placebo) work?
What is Sham-transplantation (placebo) used for?
Who makes Sham-transplantation (placebo)?
What development phase is Sham-transplantation (placebo) in?
Related
- Manufacturer: Assistance Publique - Hôpitaux de Paris — full pipeline
- Indication: Drugs for Treatment of various conditions in a clinical trial setting to compare with actual treatment
- Compare: Sham-transplantation (placebo) vs similar drugs
- Pricing: Sham-transplantation (placebo) cost, discount & access